Cytochrome P450 inhibitor, Avasimibe, Purity ≥98%

Cat. No.: X24-08-YM355

Cytochrome P450 inhibitor, Avasimibe, Purity ≥98%

Synonym: 166518-60-1; CI-1011; CI1011; PD 148515; [2,6-Di(propan-2-yl)phenyl] N-[2-[2,4,6-tri(propan-2-yl)phenyl]acetyl]sulfamate

  • MDL: MFCD00934956
  • CAS Number: 166518-60-1
  • Compound CID: 166558
Product Size
10 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Avasimibe, soluble in DMSO and ethanol and insoluble in water, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting cytochrome P450. It targets the ACAT, CYP1A2, CYP2C19, and CYP2C9.
Molecular Weight
501.7
Molecular Formula
C29H43NO4S
Targets
ACAT: 3.3 μM; CYP1A2: 13.9 μM; CYP2C19: 26.5 μM; CYP2C9: 2.9 μM
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 96 mg/mL (191.34 mM); Water: insoluble; Ethanol: 8 mg/mL (15.94 mM); In vivo: 2% DMSO + corn oil, 4 mg/mL
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Avasimibe is a metabolism inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of conditions like atherosclerosis.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.